PLIANT THERAPEUTICS, INC.: cashflow_operating
| Value | {"amount": -48864000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | PLIANT THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:48:42.383055+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2d8ef094-b811-43bf-bb47-6fc0f4e1785f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001746473-25-000099 · Open the official SEC filing →Retrieved: 2026-08-19T17:48:42.383055+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001746473/cashflow-operating/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2d8ef094-b811-43bf-bb47-6fc0f4e1785f
History
- no predecessors — first report